We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured
Published in Eye Care

Journal Scan / Research · June 19, 2020

Peripheral Ischemic Retinal Photocoagulation in Addition to Intravitreal Bevacizumab vs Intravitreal Bevacizumab Alone for Macular Edema Secondary to Central RVO

Retina (Philadelphia, Pa.)

 

Additional Info

Disclosure statements are available on the authors' profiles:

Retina (Philadelphia, Pa.)
Peripheral Ischemic Retinal Photocoagulation in Addition to Intravitreal Bevacizumab Versus Intravitreal Bevacizumab Alone for the Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: A Randomized Double-Masked Controlled Clinical Trial
Retina (Philadelphia, Pa.) 2020 Jun 01;40(6)1110-1117, R Nourinia, M Emamverdi, A Ramezani, Y Amizadeh, M Khorshidifar, N Behnaz, S Safi

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading